Network Interventions to Reduce Disparities in Living Kidney Donation

October 22, 2024 updated by: Jonathan Daw, Penn State University

Social Network Interventions to Reduce Race Disparities in Living Kidney Donation

For this current phase of the larger project, the investigators will survey transplant candidates as well as the participants family and friends to understand the barriers to volunteering and evaluation. This project will examine how network characteristics are associated with eventual living donor kidney transplant outcomes and test the efficacy of evidence-based interventions designed to assist kidney transplant candidates in participant donor search on a multi-center scale.

Study Overview

Detailed Description

The overall goal is to understand the process and assist participants who do not receive unsolicited offers to be evaluated as a living kidney donor in initiating and effectively conducting these critical conversations with participants kin and friends. In the search intervention, based on what they can tell investigators about the number, type, perceived health, perceived relationship, and potential willingness to donate, as well as analyses of data from the National Health and Nutrition Examination Survey (NHANES) investigators will counsel them on which members of participants family and friendship networks appear most biomedically promising as donors among the subset of these individuals that participants have not ruled out for known medical or perceived relationship reasons. In the rhetorical intervention, investigators will test non-coercive, promising verbal scripts that have proven promising in preliminary tests in vignette experiments in online and phone surveys.

AIM 1: Survey transplant candidates about their social network and transplant-related attitudes, knowledge, and characteristics; and randomize participants into one of two interventions or a control group.

AIM 2: Send network member participants a survey that measures potential donor attributes that are hypothesized to influence donation decisions, such as medical contraindications, blood type, health insurance status, and barriers to living donation.

AIM 3: Test whether participant social networks and interventions affect donation outcomes using medical records and follow-ups provided by Penn and UAB. Investigators will create the first predictive model of potential donor evaluation and actual donation. This information is critical to improve clinical practice and efforts to ethically influence the living donor search process.

Study Type

Interventional

Enrollment (Actual)

164

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35233
        • University of Alabama-Birmingham
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Penn Medicine-- University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Are KT candidates at the University of Pennsylvania or University of Alabama-Birmingham OR were identified by KT candidate from the University of Pennsylvania or University of Alabama-Birmingham as a network member
  • Are adults aged 18 or older
  • Are able and willing to consent to participation in the survey

Exclusion Criteria:

  • Person is not a KT candidate at University of Pennsylvania or University of Alabama-Birmingham OR was NOT identified by KT candidate from University of Pennsylvania or University of Alabama-Birmingham as a network member
  • Individuals who are not yet 18
  • Participant does not speak English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: No intervention
This group will only complete study survey and refer members of their family and social network for participation in a web survey.
Experimental: Script Intervention
This group will complete the survey, refer members of their family and social network for participation in a web survey, and review a set of suggested talking points and an example script to guide discussion of potential living donation with members of their network.
This intervention provides language to participants to allow them to discuss kidney transplantation with their social network.
Experimental: Search Intervention
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, and be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation.
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, and be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation.
Experimental: Both Search and Script Intervention
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation, and review a set of suggested talking points and an example script to guide discussion of potential living donation with members of their network.
This intervention provides language to participants to allow them to discuss kidney transplantation with their social network.
This group will complete the candidate survey, refer members of their family and social network for participation in a web survey, and be given information about the statistical likelihood that each member of their social network will be free of contraindications for living kidney donation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Received a living donor kidney transplant
Time Frame: up to 3 years
Living donor kidney transplant received by patient
up to 3 years
Received a deceased donor kidney transplant
Time Frame: up to 3 years
Deceased donor kidney transplant received by patient
up to 3 years
Death
Time Frame: up to 3 years
Patient died during the follow-up period
up to 3 years
Completed living kidney donor screening questionnaires
Time Frame: up to 3 years
Number of completed living kidney donation screening questionnaires completed for patient
up to 3 years
Preliminary approval from living kidney donor screening questionnaires
Time Frame: up to 3 years
Number of completed living kidney donor screening that received preliminary approval for patient
up to 3 years
Completed living kidney donor evaluations
Time Frame: up to 3 years
Number of living kidney donor evaluations completed for patient
up to 3 years
Approvals for living kidney donor candidacy
Time Frame: up to 3 years
Number of completed living kidney donor evaluations that resulted in approved living kidney donor candidacy for patient
up to 3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preference for living kidney donor
Time Frame: Immediate
A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding preference for living kidney donor
Immediate
Concerns about living kidney donation
Time Frame: Immediate
A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding concerns for living kidney donation
Immediate
Living donor kidney transplant willingness
Time Frame: Immediate
A set of survey questions asked both before and after the intervention, to assess intermediate attitude outcomes regarding living donor kidney transplant willingness
Immediate
Self-rated kidney transplant knowledge
Time Frame: Immediate
Respondent is asked to rate their level of knowledge related to kidney transplantation.
Immediate
Trust in medical institutions
Time Frame: Immediate
Respondent is asked to rate their trust in medical institutions.
Immediate
Religious views' effect on kidney transplant willingness
Time Frame: Immediate
Respondent is asked how strongly they agree that their religious views affect their willingness to pursue a kidney transplant.
Immediate

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 12, 2021

Primary Completion (Actual)

May 31, 2024

Study Completion (Actual)

May 31, 2024

Study Registration Dates

First Submitted

October 10, 2021

First Submitted That Met QC Criteria

February 15, 2022

First Posted (Actual)

February 25, 2022

Study Record Updates

Last Update Posted (Actual)

October 24, 2024

Last Update Submitted That Met QC Criteria

October 22, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End-stage Renal Disease

Clinical Trials on Script Intervention

Subscribe